Non US Residents | Contact Us | Site Map | Large Text VersionRegular Text Version

Welcome to Novartis Oncology US - This site is intended for US Residents only

 

 

 

Causes of Cancer

Disease Education

Hypercalcemia of Malignancy

 

Overview

Hypercalcemia of malignancy is an abnormal amount of calcium in the blood. When hypercalcemia of malignancy occurs in a patient with cancer, it may also be referred to as hypercalcemia of malignancy (HCM). Hypercalcemia of malignancy is a common complication among cancer patients, affecting approximately 10% to 20% of all patients at some point during the course of their disease and 20% to 40% of patients with advanced cancer.

Hypercalcemia of malignancy may occur because your cancer has spread to the bones, causing calcium to be released, or your cancer may release certain hormones that affect the normal systems that control the calcium level in your blood. Usually, you do not cause the calcium level to go up too high by drinking too much milk or by eating too many dairy products; the imbalance occurs because of your cancer.

 

 previous section | next section 

DISEASE SUPPORT PROGRAMS

Supportive tools and resources designed to meet your specific needs.

PAYING FOR TREATMENT

Paying for Treatment

Helping patients access the medication they need is one of our top priorities.

CLINICAL TRIALS

Find information about our Clinical Trials and how to participate.

HEALTHCARE PROFESSIONALS

Healthcare Professionals

Resources for doctors, nurses and office staff from Novartis Oncology.